These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 15332539)
1. [Cancer chemotherapy in DPC]. Kubota T Gan To Kagaku Ryoho; 2004 Aug; 31(8):1174-8. PubMed ID: 15332539 [TBL] [Abstract][Full Text] [Related]
2. [DPC and its implications for clinical practice in cancer treatment]. Ishikawa KB Gan To Kagaku Ryoho; 2004 Aug; 31(8):1169-73. PubMed ID: 15332538 [TBL] [Abstract][Full Text] [Related]
3. [Compared medical costs of treating ovarian cancer patients with weekly paclitaxel, carboplatin (TC) chemotherapy]. Nomura H; Nagai S; Shinohara T; Iwashita M; Yajima M; Takatoya S Gan To Kagaku Ryoho; 2007 Jul; 34(7):1091-4. PubMed ID: 17637546 [TBL] [Abstract][Full Text] [Related]
4. [[How to finance chemotherapy with new cancer drugs?]. Livartowski A; Beuzeboc P; Le Vu B; Courbard M; Pierga JY; Extra JM; Scholl S; Pouillart P Bull Cancer; 2000 Oct; 87(10):745-54. PubMed ID: 11084538 [TBL] [Abstract][Full Text] [Related]
5. [Impact of the chemotherapy protocols for metastatic breast cancer on the treatment cost and the survival time of 371 patients treated in three hospitals of the Rhone-Alpes region]. Paviot BT; Bachelot T; Clavreul G; Jacquin JP; Mille D; Rodrigues JM Bull Cancer; 2009 Oct; 96(10):929-40. PubMed ID: 19696006 [TBL] [Abstract][Full Text] [Related]
6. Clinical course of breast cancer patients with metastases limited to the liver treated with chemotherapy. Er O; Frye DK; Kau SW; Broglio K; Valero V; Hortobagyi GN; Arun B Cancer J; 2008; 14(1):62-8. PubMed ID: 18303485 [TBL] [Abstract][Full Text] [Related]
7. [Current status and problems in the chemotherapy of our outpatient clinic in the department of clinical oncology]. Sakuyama T; Aiba K; Inoue D; Kobayashi T; Hirano A; Uno S; Ichiba T; Mohri J; Ochiai K Gan To Kagaku Ryoho; 2005 Dec; 32 Suppl 1():4-8. PubMed ID: 16422473 [TBL] [Abstract][Full Text] [Related]
8. Frequency and cost of chemotherapy-related serious adverse effects in a population sample of women with breast cancer. Hassett MJ; O'Malley AJ; Pakes JR; Newhouse JP; Earle CC J Natl Cancer Inst; 2006 Aug; 98(16):1108-17. PubMed ID: 16912263 [TBL] [Abstract][Full Text] [Related]
9. [Treatment of 37 surgical cancers with associated or isolated chemotherapy]. Montezin J Bull Mem Soc Chir Paris; 1971; 61(6):352-68. PubMed ID: 5152093 [No Abstract] [Full Text] [Related]
10. [Our outpatient cases for home anti-cancer chemotherapy]. Midorikawa Y; Suzuki K; Kasuga T; Takemura A Gan To Kagaku Ryoho; 2005 Dec; 32 Suppl 1():1-3. PubMed ID: 16422472 [TBL] [Abstract][Full Text] [Related]
11. Adjuvant chemotherapy for colon cancer--analysis of treatment costs from the perspective of statutory sickness funds. Görner M; Riemer-Hommel P Z Gastroenterol; 2008 Jul; 46(7):681-8. PubMed ID: 18618379 [TBL] [Abstract][Full Text] [Related]
12. [Chemotherapy and DPC, prospective payment]. Ishikawa KB Gan To Kagaku Ryoho; 2006 Feb; 33(2):159-63. PubMed ID: 16484849 [TBL] [Abstract][Full Text] [Related]
13. Metastatic breast cancer with liver metastases: a registry analysis of clinicopathologic, management and outcome characteristics of 500 women. Pentheroudakis G; Fountzilas G; Bafaloukos D; Koutsoukou V; Pectasides D; Skarlos D; Samantas E; Kalofonos HP; Gogas H; Pavlidis N Breast Cancer Res Treat; 2006 Jun; 97(3):237-44. PubMed ID: 16322882 [TBL] [Abstract][Full Text] [Related]
14. [Diagnostic procedure combination in gastric cancer treatment]. Terashima M; Saze Z; Gotoh M; Yamatani S Gan To Kagaku Ryoho; 2007 Jan; 34(1):35-40. PubMed ID: 17220667 [TBL] [Abstract][Full Text] [Related]
15. Management of metastatic breast cancer: are we prepared to cope with our own success? Jimeno A; Cortés-Funes H; Colomer R Br J Cancer; 2004 Dec; 91(12):2101; author reply 2102. PubMed ID: 15599385 [No Abstract] [Full Text] [Related]
16. Palliative chemotherapy in elderly patients with common metastatic malignancies: A Hellenic Cooperative Oncology Group registry analysis of management, outcome and clinical benefit predictors. Pentheroudakis G; Fountzilas G; Kalofonos HP; Golfinopoulos V; Aravantinos G; Bafaloukos D; Papakostas P; Pectasides D; Christodoulou C; Syrigos K; Economopoulos T; Pavlidis N; Crit Rev Oncol Hematol; 2008 Jun; 66(3):237-47. PubMed ID: 18243010 [TBL] [Abstract][Full Text] [Related]
17. [A case of advanced gastric cancer successfully treated with TS-1/CDDP combination chemotherapy, able to maintain CR for more than two years against multiple liver metastases]. Meguro E; Kimura T; Noda Y; Matsumoto Y; Irinoda T; Hayakawa Y; Kobayashi M; Takagane A; Hioki J Gan To Kagaku Ryoho; 2007 Feb; 34(2):249-52. PubMed ID: 17301537 [TBL] [Abstract][Full Text] [Related]
18. Is adjuvant therapy for older patients with node (+) early breast cancer cost-effective? Naeim A; Keeler EB Breast Cancer Res Treat; 2005 Nov; 94(2):95-103. PubMed ID: 16261407 [TBL] [Abstract][Full Text] [Related]
19. [Our outpatient cases for home anti-cancer chemotherapy using a CV port and a portable pump system]. Midorikawa Y; Nakachi T; Kasuga T Gan To Kagaku Ryoho; 2006 Dec; 33 Suppl 2():264-6. PubMed ID: 17469355 [TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of intensive adjuvant chemotherapy for high-risk breast cancer: is tailored and dose-escalated chemotherapy with growth factor support (GFS) more costly and less effective than marrow-supported high-dose chemotherapy - results from a randomized study. Kellokumpu-Lehtinen P; Bergh J; Salminen E; Wiklund T; Lehtinen S; Aronen P; Sintonen H Acta Oncol; 2007; 46(2):146-52. PubMed ID: 17453362 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]